Patent · US Active

Method for producing a transdermal therapeutic system which contains a D2 agonist

US10322093B2 · kind B2 · utility

1Cited by

66References

19Claims

0Family size

Assignees

UCB BIOPHARMA SRL · BE
LTS Lohmann Therapie-Systeme AG · DE

Inventors

Walter Mueller · Andernach, DE
James V. Peck · Brooks Road, US

Key dates

Filing date	Sep 7, 2004
Grant date	Jun 18, 2019
Priority date	—
Expiry date	Mar 14, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A substantially solvent-free matrix layer containing (−)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol is produced by adding an active substance to an adhesive solution, coating the resultant active substance-containing adhesive solution onto a suitable sheet, and removing the solvents in a drying process to give said substantially solvent-free matrix layer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.